BioProspect/Ensystex termiticide deal
The Australian biotechnology company, BioProspect (Brisbane, Queensland), has entered into a product evaluation agreement with US pest control firm Ensystex (Fayetteville, North Carolina). Ensystex will test BioProspect’s eremophilone oil-based termiticide, Termilone, through commercial application equipment for termite control in buildings. The evaluations will take place over two years in countries including Australia, the US and Japan. The companies will then have the option of agreeing on the supply and distribution of Termilone. BioProspect hopes to receive Australian approval for the product in 12-18 months ( Agrow No 557, p 22).